StimCardio is a medical device company developing wearable neuromodulation technology for the management of cardiac rhythm disorders.
StimCardio has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
StimCardio's investors include HeartX, New York Angels, Catalyst Health Ventures, Shane Neman, Particular Ventures.
StimCardio is headquartered in Los Angeles, United States.
StimCardio is a medical device company developing wearable neuromodulation technology for the management of cardiac rhythm disorders.
StimCardio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StimCardio — Funding & Investors." VCBacked, October 29, 2026, https://www.vcbacked.co/company/stimcardio. Accessed November 4, 2026.
VCBacked. (2026). StimCardio — Funding & Investors. Retrieved November 4, 2026, from https://www.vcbacked.co/company/stimcardio
{{cite web |title=StimCardio — Funding & Investors |url=https://www.vcbacked.co/company/stimcardio |website=VCBacked |access-date=November 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at StimCardio? Request a listing update